Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Sinovac Biotech Ltd.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 84.2M 33.4M 56.84M 49.22M 72.52M
Cost of Goods Sold (COGS) incl. D&A 20.76M 18.13M 22.56M 20.69M 21.27M
COGS excluding D&A 18.52M 13.9M 17.74M 16.21M 14.53M
Depreciation & Amortization Expense 2.24M 4.23M 4.83M 4.49M 6.74M
Depreciation 1.82M 3.69M 4.56M 4.26M 6M
Amortization of Intangibles 418,867 546,623 268,345 227,864 435,000
Gross Income 63.44M 15.27M 34.28M 28.52M 51.25M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 22.59M 29.31M 31.9M 47.98M 42.42M
Research & Development 4.41M 8.64M 9.69M 17.17M 8.38M
Other SG&A 18.18M 20.68M 22.21M 30.81M 34.03M
Other Operating Expense (1.3M) (1.92M) 0 0 0
Unusual Expense 169,678 1.24M 454,973 - 57,000
EBIT after Unusual Expense (169,678) (1.24M) (454,973) - (57,000)
Non Operating Income/Expense (33,550) 390,784 1.73M 1.15M 362,000
Non-Operating Interest Income 143,464 1.13M 1.4M 2.37M 2.17M
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 534,455 1.33M 980,443 2.23M 3.1M
Gross Interest Expense 534,455 1.33M 980,443 2.23M 3.1M
Interest Capitalized 0 0 0 0 0
Pretax Income 41.55M (13.31M) 4.67M (19.63M) 8.15M
Income Tax 11.14M (703,882) 5.07M (883,897) (2.23M)
Income Tax - Current Domestic 9.88M 1M 2.22M (866,693) 0
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic 1.26M (1.71M) 2.85M (17,204) (2.23M)
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 30.41M (12.6M) (399,694) (18.75M) 10.37M
Minority Interest Expense 10.45M (4.09M) 445,002 (3.9M) 2.93M
Net Income 19.96M (8.51M) (844,696) (14.85M) 7.44M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 19.96M (8.51M) (844,696) (14.85M) 7.44M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 19.96M (8.51M) (844,696) (14.85M) 7.44M
EPS (Basic) 0.47 (0.16) (0.02) (0.27) 0.13
Basic Shares Outstanding 42.58M 53.06M 54.61M 54.93M 55.3M
EPS (Diluted) 0.46 (0.16) (0.02) (0.27) 0.13
Diluted Shares Outstanding 42.98M 53.06M 54.61M 54.93M 55.8M
EBITDA 44.39M (7.89M) 7.21M (14.97M) 15.58M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.